The partnership is said to have a three-year financial commitment for which GSK has made an initial payment of $70m. GSK has signed a three-year partnership agreement with Tempus to enhance clinical trial design, expedite subject enrolment and detect drug targets. Under the…
UK sees decline in clinical trials over last five years, ABPI finds
According to the ABPI report, some pharmaceutical firms are forced to conduct their trials in other countries. The Association of the British Pharmaceutical Industry (ABPI) has reported that the number of industry clinical trials started in the UK each year dropped by…
Walmart follows CVS, Walgreens into clinical trial sector
Walmart is the latest US retail pharmacy giant to announce its intention of disrupting the clinical trials category, with the launch of a new institute that pledges to increase and diversify community access to healthcare research. The Walmart Healthcare Research…
Digital therapeutic cuts IPF-related anxiety by half in pilot study
Swedish digital health company Alex Therapeutics has reported encouraging results in a trial of a digital therapeutic (DTx) for anxiety in patients with the respiratory disease idiopathic pulmonary fibrosis (IPF). The cognitive behavioural therapy-based DTx – called Almee (formerly VP04)…
Dana-Farber’s computer platform makes patient matching process easier
MatchMiner can be used by a clinician or an oncologist to look up trial options for a patient. Dana-Farber Cancer Institute designers have reported in a new study that its computer platform makes the patient matching process easier, as well…
Martis Capital invests in Alcanza Clinical Research
Alcanza is changing the model for research access to underrepresented people to enhance inclusion in clinical trials. Middle market healthcare fund Martis Capital has invested in Alcanza Clinical Research in order to meet the pressing requirements of equitable healthcare. Established…
Airway doses first subject in bronchopulmonary dysplasia trial in Spain
Zelpultide alfa has received Orphan Drug Designation from the European Medicines Agency and the US FDA. Airway Therapeutics has dosed the first subject in its Phase Ib clinical trial of zelpultide alfa (rhSP-D) in Spain for preventative usage in very preterm infants…
Satisfai, Virgo, and Alimentiv to boost trials using AI-powered technology
Satisfai and Virgo will merge expertise with Alimentiv to attain AI-driven precision imaging’s full potential in a GI trial space. Satisfai Health and Virgo Surgical Video Solutions have entered a strategic collaboration with Alimentiv to leverage artificial intelligence (AI)-powered technology to boost…
Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound
Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound ~ To Support More Accurate Diagnosis and Treatment of Pancreaticobiliary and Lung Diseases ~ TOKYO & HAMBURG, Oct 7, 2022 – (JCN Newswire) – Olympus Corporation (Olympus), a global…
AstraZeneca pays record 660% premium for gene editing company LogicBio
AstraZeneca’s rare disease firm Alexion is set to expand its genomic medicine portfolio with the acquisition of gene editing specialist LogicBio Therapeutics, in a deal worth approximately $68 million. US-based LogicBio is a clinical-stage genetic medicine company focused on genome…